Although the majority of PET radiopharmaceuticals in clinical and research use are labeled with the four common PET radionuclides, 15O, 13N, 11C and 18F, a number of metal radionuclides have been studied. 68Ga, produced from a 68Ge/68Ga generator, was initially used for brain imaging in 1964 [1, 2]. The 82Sr/82Rb generator was originally developed by researchers at the Squibb Institute for Medical Research [3]. This gen- erator, now marketed by Bracco, is the only industry- approved PET radiopharmaceutical with a Food and Drug Administration New Drug Application (NDA) in the United States. Over the past several years, there has been increasing interest in other metal-based radionu- clides, particularly nuclides of copper, 66Ga and 86Y. Several of these nuclides can be distributed from a central production site and thereby have the potential for use in PET centers without a cyclotron. In this chapter the available metal PET radionuclides will be summarized and those with the greatest poten- tial for widespread use will be discussed in detail.
CITATION STYLE
McQuade, P., McCarthy, D. W., & Welch, M. J. (2005). Metal Radionuclides for PET Imaging. In Positron Emission Tomography (pp. 237–250). Springer London. https://doi.org/10.1007/1-84628-007-9_11
Mendeley helps you to discover research relevant for your work.